Haynes and Boone represented BioSig Technologies, Inc. in the offering.
BioSig Technologies, Inc. (Nasdaq: BSGM) executed a $17.5 million registered direct offering of its common stock, which closed on June 26, 2020.
BioSig Technologies is a medical technology company commercializing a proprietary biomedical signal processing platform designed to improve signal fidelity and uncover the full range of electrocardiogram (ECG) and intra-cardiac signals.
Haynes and Boone represented BioSig with a team led by New York Partner Rick Werner (Picture), co-chair of the Capital Markets and Securities Practice Group, and Jayun Koo, a partner in the New York Capital Markets and Securities Practice Group. They were assisted by New York Associate Eloise Rotenberg.
Law Firms: Haynes and Boone;
Clients: BioSig Technologies;